nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.149	0.173	CbGbCtD
Carbinoxamine—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.104	0.121	CbGbCtD
Carbinoxamine—CYP2C8—Progesterone—uterine cancer	0.099	0.115	CbGbCtD
Carbinoxamine—CYP2C19—Progesterone—uterine cancer	0.0831	0.0964	CbGbCtD
Carbinoxamine—CYP2C9—Progesterone—uterine cancer	0.0691	0.0801	CbGbCtD
Carbinoxamine—CYP2D6—Progesterone—uterine cancer	0.0632	0.0733	CbGbCtD
Carbinoxamine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0606	0.0703	CbGbCtD
Carbinoxamine—CYP2E1—Etoposide—uterine cancer	0.0593	0.0688	CbGbCtD
Carbinoxamine—CYP2C8—Etoposide—uterine cancer	0.0443	0.0514	CbGbCtD
Carbinoxamine—CYP3A4—Progesterone—uterine cancer	0.0402	0.0466	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—uterine cancer	0.0399	0.0463	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—uterine cancer	0.0193	0.0224	CbGbCtD
Carbinoxamine—CYP3A4—Etoposide—uterine cancer	0.018	0.0209	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—uterine cancer	0.0123	0.0142	CbGbCtD
Carbinoxamine—Neuritis—Progesterone—uterine cancer	0.00391	0.029	CcSEcCtD
Carbinoxamine—Neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00355	0.0263	CcSEcCtD
Carbinoxamine—Mitotane—CYP11A1—uterine cancer	0.00298	1	CrCbGaD
Carbinoxamine—Nasal congestion—Progesterone—uterine cancer	0.00233	0.0172	CcSEcCtD
Carbinoxamine—Euphoric mood—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.0168	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00213	0.0158	CcSEcCtD
Carbinoxamine—Diplopia—Progesterone—uterine cancer	0.00212	0.0157	CcSEcCtD
Carbinoxamine—Irritability—Progesterone—uterine cancer	0.00202	0.015	CcSEcCtD
Carbinoxamine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.0136	CcSEcCtD
Carbinoxamine—Urinary retention—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.0135	CcSEcCtD
Carbinoxamine—Sweating increased—Progesterone—uterine cancer	0.00179	0.0132	CcSEcCtD
Carbinoxamine—Pollakiuria—Progesterone—uterine cancer	0.00169	0.0125	CcSEcCtD
Carbinoxamine—Chest discomfort—Etoposide—uterine cancer	0.00169	0.0125	CcSEcCtD
Carbinoxamine—Drowsiness—Progesterone—uterine cancer	0.00163	0.0121	CcSEcCtD
Carbinoxamine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.012	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Progesterone—uterine cancer	0.0016	0.0119	CcSEcCtD
Carbinoxamine—Pollakiuria—Medroxyprogesterone Acetate—uterine cancer	0.00153	0.0114	CcSEcCtD
Carbinoxamine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.011	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00145	0.0107	CcSEcCtD
Carbinoxamine—Tinnitus—Progesterone—uterine cancer	0.00137	0.0101	CcSEcCtD
Carbinoxamine—Tension—Progesterone—uterine cancer	0.00125	0.00928	CcSEcCtD
Carbinoxamine—Nervousness—Progesterone—uterine cancer	0.00124	0.00918	CcSEcCtD
Carbinoxamine—Tinnitus—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00918	CcSEcCtD
Carbinoxamine—Vision blurred—Progesterone—uterine cancer	0.0012	0.00891	CcSEcCtD
Carbinoxamine—Tremor—Progesterone—uterine cancer	0.0012	0.00886	CcSEcCtD
Carbinoxamine—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00883	CcSEcCtD
Carbinoxamine—Vertigo—Progesterone—uterine cancer	0.00115	0.0085	CcSEcCtD
Carbinoxamine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00114	0.00841	CcSEcCtD
Carbinoxamine—Palpitations—Progesterone—uterine cancer	0.00113	0.00836	CcSEcCtD
Carbinoxamine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.00832	CcSEcCtD
Carbinoxamine—Neuritis—Epirubicin—uterine cancer	0.00112	0.00831	CcSEcCtD
Carbinoxamine—Convulsion—Progesterone—uterine cancer	0.00111	0.00819	CcSEcCtD
Carbinoxamine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00108	0.00803	CcSEcCtD
Carbinoxamine—Agranulocytosis—Dactinomycin—uterine cancer	0.00108	0.00798	CcSEcCtD
Carbinoxamine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00787	CcSEcCtD
Carbinoxamine—Confusional state—Progesterone—uterine cancer	0.00105	0.00778	CcSEcCtD
Carbinoxamine—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.0077	CcSEcCtD
Carbinoxamine—Neuritis—Doxorubicin—uterine cancer	0.00104	0.00769	CcSEcCtD
Carbinoxamine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00757	CcSEcCtD
Carbinoxamine—Tachycardia—Progesterone—uterine cancer	0.00102	0.00753	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Progesterone—uterine cancer	0.00101	0.00746	CcSEcCtD
Carbinoxamine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.001	0.00742	CcSEcCtD
Carbinoxamine—Anorexia—Progesterone—uterine cancer	0.000994	0.00736	CcSEcCtD
Carbinoxamine—Hypotension—Progesterone—uterine cancer	0.000974	0.00721	CcSEcCtD
Carbinoxamine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000953	0.00705	CcSEcCtD
Carbinoxamine—Insomnia—Progesterone—uterine cancer	0.000943	0.00698	CcSEcCtD
Carbinoxamine—Paraesthesia—Progesterone—uterine cancer	0.000936	0.00693	CcSEcCtD
Carbinoxamine—Chills—Dactinomycin—uterine cancer	0.000931	0.00689	CcSEcCtD
Carbinoxamine—Somnolence—Progesterone—uterine cancer	0.000927	0.00686	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000925	0.00685	CcSEcCtD
Carbinoxamine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000922	0.00683	CcSEcCtD
Carbinoxamine—Dyspepsia—Progesterone—uterine cancer	0.000918	0.00679	CcSEcCtD
Carbinoxamine—Sweating increased—Etoposide—uterine cancer	0.000914	0.00676	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000913	0.00676	CcSEcCtD
Carbinoxamine—Decreased appetite—Progesterone—uterine cancer	0.000906	0.00671	CcSEcCtD
Carbinoxamine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000901	0.00667	CcSEcCtD
Carbinoxamine—Fatigue—Progesterone—uterine cancer	0.000899	0.00665	CcSEcCtD
Carbinoxamine—Constipation—Progesterone—uterine cancer	0.000892	0.0066	CcSEcCtD
Carbinoxamine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000883	0.00653	CcSEcCtD
Carbinoxamine—Feeling abnormal—Progesterone—uterine cancer	0.000859	0.00636	CcSEcCtD
Carbinoxamine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000855	0.00633	CcSEcCtD
Carbinoxamine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000848	0.00628	CcSEcCtD
Carbinoxamine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.00622	CcSEcCtD
Carbinoxamine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000832	0.00616	CcSEcCtD
Carbinoxamine—Urticaria—Progesterone—uterine cancer	0.000828	0.00613	CcSEcCtD
Carbinoxamine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000821	0.00608	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Etoposide—uterine cancer	0.00082	0.00607	CcSEcCtD
Carbinoxamine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000815	0.00603	CcSEcCtD
Carbinoxamine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000808	0.00598	CcSEcCtD
Carbinoxamine—Agranulocytosis—Etoposide—uterine cancer	0.000781	0.00578	CcSEcCtD
Carbinoxamine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000779	0.00576	CcSEcCtD
Carbinoxamine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000751	0.00556	CcSEcCtD
Carbinoxamine—Asthenia—Progesterone—uterine cancer	0.000748	0.00554	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000722	0.00534	CcSEcCtD
Carbinoxamine—Diarrhoea—Progesterone—uterine cancer	0.000713	0.00528	CcSEcCtD
Carbinoxamine—Anorexia—Dactinomycin—uterine cancer	0.000703	0.0052	CcSEcCtD
Carbinoxamine—Photosensitivity—Epirubicin—uterine cancer	0.000693	0.00513	CcSEcCtD
Carbinoxamine—Dizziness—Progesterone—uterine cancer	0.00069	0.0051	CcSEcCtD
Carbinoxamine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000678	0.00502	CcSEcCtD
Carbinoxamine—Chills—Etoposide—uterine cancer	0.000674	0.00499	CcSEcCtD
Carbinoxamine—Vomiting—Progesterone—uterine cancer	0.000663	0.00491	CcSEcCtD
Carbinoxamine—Headache—Progesterone—uterine cancer	0.000653	0.00483	CcSEcCtD
Carbinoxamine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000647	0.00478	CcSEcCtD
Carbinoxamine—Photosensitivity—Doxorubicin—uterine cancer	0.000641	0.00474	CcSEcCtD
Carbinoxamine—Decreased appetite—Dactinomycin—uterine cancer	0.000641	0.00474	CcSEcCtD
Carbinoxamine—Fatigue—Dactinomycin—uterine cancer	0.000635	0.0047	CcSEcCtD
Carbinoxamine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000625	0.00462	CcSEcCtD
Carbinoxamine—Nausea—Progesterone—uterine cancer	0.000619	0.00458	CcSEcCtD
Carbinoxamine—Diplopia—Epirubicin—uterine cancer	0.000608	0.0045	CcSEcCtD
Carbinoxamine—Feeling abnormal—Dactinomycin—uterine cancer	0.000607	0.0045	CcSEcCtD
Carbinoxamine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000601	0.00445	CcSEcCtD
Carbinoxamine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000592	0.00438	CcSEcCtD
Carbinoxamine—Vertigo—Etoposide—uterine cancer	0.000587	0.00435	CcSEcCtD
Carbinoxamine—Convulsion—Etoposide—uterine cancer	0.000566	0.00419	CcSEcCtD
Carbinoxamine—Diplopia—Doxorubicin—uterine cancer	0.000563	0.00417	CcSEcCtD
Carbinoxamine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000561	0.00415	CcSEcCtD
Carbinoxamine—Confusional state—Etoposide—uterine cancer	0.000538	0.00398	CcSEcCtD
Carbinoxamine—Asthenia—Dactinomycin—uterine cancer	0.000529	0.00391	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Etoposide—uterine cancer	0.000522	0.00387	CcSEcCtD
Carbinoxamine—Tachycardia—Etoposide—uterine cancer	0.000521	0.00385	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Etoposide—uterine cancer	0.000516	0.00382	CcSEcCtD
Carbinoxamine—Anorexia—Etoposide—uterine cancer	0.000508	0.00376	CcSEcCtD
Carbinoxamine—Diarrhoea—Dactinomycin—uterine cancer	0.000504	0.00373	CcSEcCtD
Carbinoxamine—Hypotension—Etoposide—uterine cancer	0.000498	0.00369	CcSEcCtD
Carbinoxamine—Pollakiuria—Epirubicin—uterine cancer	0.000486	0.0036	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00048	0.00355	CcSEcCtD
Carbinoxamine—Paraesthesia—Etoposide—uterine cancer	0.000479	0.00355	CcSEcCtD
Carbinoxamine—Somnolence—Etoposide—uterine cancer	0.000474	0.00351	CcSEcCtD
Carbinoxamine—Drowsiness—Epirubicin—uterine cancer	0.000469	0.00347	CcSEcCtD
Carbinoxamine—Vomiting—Dactinomycin—uterine cancer	0.000469	0.00347	CcSEcCtD
Carbinoxamine—Decreased appetite—Etoposide—uterine cancer	0.000464	0.00343	CcSEcCtD
Carbinoxamine—Fatigue—Etoposide—uterine cancer	0.00046	0.0034	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Epirubicin—uterine cancer	0.00046	0.0034	CcSEcCtD
Carbinoxamine—Constipation—Etoposide—uterine cancer	0.000456	0.00338	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—uterine cancer	0.000449	0.00333	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000444	0.00329	CcSEcCtD
Carbinoxamine—Feeling abnormal—Etoposide—uterine cancer	0.00044	0.00325	CcSEcCtD
Carbinoxamine—Nausea—Dactinomycin—uterine cancer	0.000438	0.00324	CcSEcCtD
Carbinoxamine—Agranulocytosis—Epirubicin—uterine cancer	0.000438	0.00324	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—uterine cancer	0.000434	0.00321	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000425	0.00315	CcSEcCtD
Carbinoxamine—Urticaria—Etoposide—uterine cancer	0.000424	0.00314	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—uterine cancer	0.000405	0.003	CcSEcCtD
Carbinoxamine—Tinnitus—Epirubicin—uterine cancer	0.000392	0.0029	CcSEcCtD
Carbinoxamine—Asthenia—Etoposide—uterine cancer	0.000383	0.00283	CcSEcCtD
Carbinoxamine—Chills—Epirubicin—uterine cancer	0.000378	0.00279	CcSEcCtD
Carbinoxamine—Diarrhoea—Etoposide—uterine cancer	0.000365	0.0027	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—uterine cancer	0.000363	0.00269	CcSEcCtD
Carbinoxamine—Tension—Epirubicin—uterine cancer	0.00036	0.00266	CcSEcCtD
Carbinoxamine—Nervousness—Epirubicin—uterine cancer	0.000356	0.00263	CcSEcCtD
Carbinoxamine—Dizziness—Etoposide—uterine cancer	0.000353	0.00261	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—uterine cancer	0.000349	0.00259	CcSEcCtD
Carbinoxamine—Vision blurred—Epirubicin—uterine cancer	0.000345	0.00256	CcSEcCtD
Carbinoxamine—Vomiting—Etoposide—uterine cancer	0.000339	0.00251	CcSEcCtD
Carbinoxamine—Agitation—Epirubicin—uterine cancer	0.000337	0.00249	CcSEcCtD
Carbinoxamine—Headache—Etoposide—uterine cancer	0.000334	0.00247	CcSEcCtD
Carbinoxamine—Tension—Doxorubicin—uterine cancer	0.000333	0.00246	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—uterine cancer	0.000329	0.00244	CcSEcCtD
Carbinoxamine—Vertigo—Epirubicin—uterine cancer	0.000329	0.00244	CcSEcCtD
Carbinoxamine—Palpitations—Epirubicin—uterine cancer	0.000324	0.0024	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—uterine cancer	0.000319	0.00236	CcSEcCtD
Carbinoxamine—Convulsion—Epirubicin—uterine cancer	0.000317	0.00235	CcSEcCtD
Carbinoxamine—Nausea—Etoposide—uterine cancer	0.000317	0.00235	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—uterine cancer	0.000312	0.00231	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—uterine cancer	0.000305	0.00225	CcSEcCtD
Carbinoxamine—Confusional state—Epirubicin—uterine cancer	0.000301	0.00223	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—uterine cancer	0.0003	0.00222	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—uterine cancer	0.000294	0.00217	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Epirubicin—uterine cancer	0.000293	0.00217	CcSEcCtD
Carbinoxamine—Tachycardia—Epirubicin—uterine cancer	0.000292	0.00216	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Epirubicin—uterine cancer	0.000289	0.00214	CcSEcCtD
Carbinoxamine—Anorexia—Epirubicin—uterine cancer	0.000285	0.00211	CcSEcCtD
Carbinoxamine—Hypotension—Epirubicin—uterine cancer	0.000279	0.00207	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—uterine cancer	0.000279	0.00206	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000271	0.002	CcSEcCtD
Carbinoxamine—Insomnia—Epirubicin—uterine cancer	0.00027	0.002	CcSEcCtD
Carbinoxamine—Tachycardia—Doxorubicin—uterine cancer	0.00027	0.002	CcSEcCtD
Carbinoxamine—Paraesthesia—Epirubicin—uterine cancer	0.000268	0.00199	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000267	0.00198	CcSEcCtD
Carbinoxamine—Somnolence—Epirubicin—uterine cancer	0.000266	0.00197	CcSEcCtD
Carbinoxamine—Anorexia—Doxorubicin—uterine cancer	0.000264	0.00195	CcSEcCtD
Carbinoxamine—Dyspepsia—Epirubicin—uterine cancer	0.000263	0.00195	CcSEcCtD
Carbinoxamine—Decreased appetite—Epirubicin—uterine cancer	0.00026	0.00192	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—uterine cancer	0.000259	0.00191	CcSEcCtD
Carbinoxamine—Fatigue—Epirubicin—uterine cancer	0.000258	0.00191	CcSEcCtD
Carbinoxamine—Constipation—Epirubicin—uterine cancer	0.000256	0.00189	CcSEcCtD
Carbinoxamine—Insomnia—Doxorubicin—uterine cancer	0.00025	0.00185	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—uterine cancer	0.000248	0.00184	CcSEcCtD
Carbinoxamine—Feeling abnormal—Epirubicin—uterine cancer	0.000246	0.00182	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—uterine cancer	0.000246	0.00182	CcSEcCtD
Carbinoxamine—Dyspepsia—Doxorubicin—uterine cancer	0.000244	0.0018	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—uterine cancer	0.000241	0.00178	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—uterine cancer	0.000239	0.00177	CcSEcCtD
Carbinoxamine—Urticaria—Epirubicin—uterine cancer	0.000238	0.00176	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—uterine cancer	0.000237	0.00175	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—uterine cancer	0.000228	0.00169	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—uterine cancer	0.00022	0.00163	CcSEcCtD
Carbinoxamine—Asthenia—Epirubicin—uterine cancer	0.000215	0.00159	CcSEcCtD
Carbinoxamine—Diarrhoea—Epirubicin—uterine cancer	0.000205	0.00151	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—uterine cancer	0.000199	0.00147	CcSEcCtD
Carbinoxamine—Dizziness—Epirubicin—uterine cancer	0.000198	0.00146	CcSEcCtD
Carbinoxamine—Vomiting—Epirubicin—uterine cancer	0.00019	0.00141	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—uterine cancer	0.000189	0.0014	CcSEcCtD
Carbinoxamine—Headache—Epirubicin—uterine cancer	0.000187	0.00139	CcSEcCtD
Carbinoxamine—Dizziness—Doxorubicin—uterine cancer	0.000183	0.00135	CcSEcCtD
Carbinoxamine—Nausea—Epirubicin—uterine cancer	0.000178	0.00131	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—uterine cancer	0.000176	0.0013	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—uterine cancer	0.000173	0.00128	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—uterine cancer	0.000164	0.00122	CcSEcCtD
